chr8-144513264-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3
The NM_004260.4(RECQL4):c.2417G>A(p.Gly806Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000476 in 1,593,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G806R) has been classified as Uncertain significance.
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | ENST00000617875.6 | c.2417G>A | p.Gly806Glu | missense_variant | Exon 14 of 21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
| RECQL4 | ENST00000621189.4 | c.1346G>A | p.Gly449Glu | missense_variant | Exon 13 of 20 | 1 | ENSP00000483145.1 | |||
| RECQL4 | ENST00000534626.6 | c.634-126G>A | intron_variant | Intron 5 of 7 | 5 | ENSP00000477457.1 | ||||
| ENSG00000265393 | ENST00000580385.1 | n.272-342C>T | intron_variant | Intron 1 of 1 | 3 | 
Frequencies
GnomAD3 genomes  0.000322  AC: 49AN: 152114Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.000119  AC: 26AN: 218962 AF XY:  0.000115   show subpopulations 
GnomAD4 exome  AF:  0.000493  AC: 710AN: 1441308Hom.:  0  Cov.: 47 AF XY:  0.000479  AC XY: 343AN XY: 716686 show subpopulations 
Age Distribution
GnomAD4 genome  0.000322  AC: 49AN: 152114Hom.:  0  Cov.: 33 AF XY:  0.000310  AC XY: 23AN XY: 74296 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Baller-Gerold syndrome;C1849453:Rapadilino syndrome;C5203410:Rothmund-Thomson syndrome type 2    Uncertain:1 
- -
Baller-Gerold syndrome    Uncertain:1 
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 806 of the RECQL4 protein (p.Gly806Glu). This variant is present in population databases (rs762456224, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 239726). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
RECQL4-related disorder    Uncertain:1 
The RECQL4 c.2417G>A variant is predicted to result in the amino acid substitution p.Gly806Glu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.028% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at